that will be great if they can consolidate so then RRS rocket should be ready to fly. I would suggest that they should also change the company name. Also strong strategies in cutting costs and no more taking debt please.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%